Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0da7ef806e46523acd5717bcc068eddd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15eca5f1bcee6eeb3cc1fd70cfa856f0 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48 |
filingDate |
2005-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca53a4576e7d0824ddbf14eebcf3923 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b250dfde25c1ff6c03451e9d632f298 |
publicationDate |
2009-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009317794-A1 |
titleOfInvention |
Biological indicator |
abstract |
A kinase is used in a biological indicator for validation of treatment processes designed to reduce the amount or activity of a biological agent in a sample. The indication can be used for validation of sterilisation treatment. The formation of ATP from a substrate comprising ADP is measured via the liciferin/luciferate system in a luminameter. Thermostable adenylate kinase from sulfolobus acidocaldarius is especially suitable for the validation of procedures to inactivate transmissible spongiform encephalopathy agents. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10466245-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011177539-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9416396-B2 |
priorityDate |
2004-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |